title: Successful treatment of Bowen's disease with topical maxacalcitol.
authors.forename: Tadashi
authors.initials: T
authors.lastname: Karashima
authors.forename: Keiko
authors.initials: K
authors.lastname: Hashikawa
authors.forename: Fumitake
authors.initials: F
authors.lastname: Ono
authors.forename: Hironobu
authors.initials: H
authors.lastname: Eguchi
authors.forename: Takahiro
authors.initials: T
authors.lastname: Hamada
authors.forename: Norito
authors.initials: N
authors.lastname: Ishii
authors.forename: Teruki
authors.initials: T
authors.lastname: Dainichi
authors.forename: Shinichiro
authors.initials: S
authors.lastname: Yasumoto
authors.forename: Daisuke
authors.initials: D
authors.lastname: Tsuruta
authors.forename: Takashi
authors.initials: T
authors.lastname: Hashimoto
mesh_terms: D000279:Administration, Cutaneous; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D014408:Biomarkers, Tumor / Q000032:analysis; D001706:Biopsy; D001913:Bowen's Disease / Q000737:chemistry / Q000188:drug therapy* / Q000473:pathology; D002117:Calcitriol / Q000008:administration & dosage / Q000031:analogs & derivatives*; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008565:Membrane Proteins / Q000032:analysis; D012878:Skin Neoplasms / Q000737:chemistry / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D008565:Membrane Proteins; C064554:loricrin; D002117:Calcitriol; C051883:maxacalcitol